Investors Center

OUR VALUE PROPOSITION

Gate2Brain is an early-stage biotech company that aims to improve drug delivery across biological barriers using an innovative peptide-based patented technology platform.

Using our technology, our goal is to provide improved permeable, non-antigenic, stable, receptor-specific, soluble, non-invasive, and cost-effective therapeutic candidates with potential applications in a large number of therapeutic fields.


WHY INVEST IN GATE2BRAIN

• An extensive patent portfolio protects our intellectual property rights.

• Our technology platform for the delivery of therapeutics is highly innovative.

• We target the treatment of rare diseases, such as pediatric solid tumors of the central nervous system (brain).

• We are supported by a highly prestigious board and leadership team.

• Our investor partners endorse our discipline in Capital Management.


COMPANY STRATEGY

• To become a world leading company using a cutting-edge delivery technology.

• To provide affordable health solutions.

• To recruit a bold, passionate, fearless and innovative team.

Latest News

THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansión
📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kids
Womenstartupawardsgate2Brain

Let’s start a conversation

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.